Radiopharm Theranostics Files 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Feb 24, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Radiopharm Theranostics filed a 6-K, confirming 20-F annual reports and no 12g3-2(b) info.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on February 24, 2025, reporting information for the month of February 2025. The company is a foreign private issuer and will file its annual reports under Form 20-F. The filing does not indicate that the registrant is furnishing information under Rule 12g3-2(b).
Why It Matters
This filing provides routine updates for foreign private issuers, informing investors about the company's reporting status and adherence to SEC regulations.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain material new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- 20250224 (date) — Filing Date
- February 2025 (date) — Reporting Period
- Form 20-F (document) — Annual Report Form
- Rule 12g3-2(b) (regulation) — Information Furnishing Rule
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer, used to furnish information to the SEC for the month of February 2025.
Which form will Radiopharm Theranostics Limited use for its annual reports?
Radiopharm Theranostics Limited will file its annual reports under cover of Form 20-F.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the filing indicates 'No' for whether the registrant is furnishing information pursuant to Rule 12g3-2(b).
What is the SEC file number for Radiopharm Theranostics Limited?
The SEC file number for Radiopharm Theranostics Limited is 001-41621.
What is the principal executive office address of Radiopharm Theranostics Limited?
The principal executive office address is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 24, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).